The Technicalities of a Quality Management System under MDR / … · 2017-12-06 · • At least...
Transcript of The Technicalities of a Quality Management System under MDR / … · 2017-12-06 · • At least...
Slide 1
The Technicalities of a Quality Management System
under MDR / IVDRDecember 5, 2017
Jonathan Bretz, OT/L, MBA, RACRSQM Associates, LLC
Slide 2
Introduction
Jonathan Bretz, OT/L, MBA, PresidentRSQM Associates, LLC
• Over 40 years experience in the medical device field - private and provider sectors. Has held various senior executive positions – in marketing/sales, operations, and then coordinating, managing and staffing a regulatory and quality departments.
• Responsible for regulatory submission to the FDA, EU and Health Canada and managing Quality systems.
• Guided over 40 companies to implement UDI programs, update and create quality systems, regulatory submissions (FDA and EU), project management, software/equipment validation and quality system, UDI program and HIPAA assessment/auditing.
Slide 3
“To ensure that devices manufactured in series production continue to be in conformity with the requirements of this Regulation and that experience from the use of the devices they manufacture is taken into account for the production process, all manufacturers should have a quality management system and a post-market surveillance system in place which should be proportionate to the risk class and the type of the device in question. In addition, in order to minimize risks or prevent incidents related to devices, manufacturers should establish a system for risk management and a system for reporting of incidents and field safety corrective actions.” (32[31])
MDR[IVDR] Introduction…
Slide 4
Technicalities of a QualityManagement System
Quality Management
System
1. Transition Timeline
2. Major Quality Management
System Requirements
3. Bringing it all Together
4. MDR / IVDR Quality System Requirements
5. General Obligations of Manufacturers
• Overview• Recommended Procedures
Slide 7
Classification… (Article 51 [47])
• Check to see if your devices have been re-classified• Update classification processes to reflect changes• Revise Technical File process to include new
classification rules and classification justification• Change in classification may impact your quality
system procedures
Slide 8
Responsible Person [Article 15]
• At least one responsible person with requisite expertise in medical devices [in vitro diagnostic medical devices] and shall have… (34[33] / Article 15 [Article 15])
- a diploma, certificate or other evidence of formal qualification, awarded on completion of a university degree or of a course of study…, and at least one year of professional experience in regulatory affairs or in quality management systems relating to medical devices [in vitro diagnostic medical devices]; OR
- four years of professional experience in regulatory affairs or in quality management systems relating to medical devices [in vitro diagnostic medical devices].
Slide 9
Organizations Must…• Responsibilities and authority defined in job description• Not disadvantage person within the organization in relation to proper fulfillment of
responsibilities, whether employee or not• Register persons name and address and contact
information in Eudamed database
Slide 10
Post-Market Surveillance System…• Establish a comprehensive post-market surveillance system… (74[75])
- Implement process in accordance with Chapter VII and Annex III- Set up PMS and PMCF plan and reporting system; updates and summaries are
mandatory- Update CER with PMS data (bi) annually- Periodic Safety Update Reports (86[81])
- Summary of Safety & Clinical Performance[Summary of Safety & Performance]
- Communication with Competent Authorities, NB, other economic operators, users
Slide 11
Post-Market Reports…MDR IVDR PSUR SSCP [SSP]
Class I Class A, BStrictly N/A, however Article
85 [80] – Class I [A/B]PMS Report updated
“when necessary”
-
Class Im, Ir, Is - -
Class IIa - As necessary and at least every 2 years -
Class IIb Class C, D Annual -
Class IIb Implantables - Annual to NB(Eudamed)
Annual to NB(Eudamed)
Class III - Annual to NB(Eudamed)
Annual to NB(Eudamed)
Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 12
Manufacturers Shall…• … establish, document, implement and maintain a
system for risk management… (Article 10, Paragraph 2)
• … establish, document, implement, maintain, keep up-to-date and continually improve a quality management system… (Article 10, Paragraph 9[8])
Slide 13
Notified Bodies Involved with Following Manufacturers…
Class I measuring
Class I sterile
Class I reusable instruments
Class IIa/IIb, III, implantables
Slide 14
Supply Chain Control• Contracts with economic operators• Critical suppliers must be part of technical
documentation and QMS• Complaint reporting timelines, vigilance and FSCA
require your economic operators promptly provide information• Private label companies must have complete technical files;
update OEM / PL agreements• Manufacturer is responsible for organizing and training supply chain stakeholders
Slide 15
General Safety & Performance Requirements• Process to ensure sufficient effectiveness & performance data is available• Risk management process to be continuous procedure throughout entire life
cycle of product• ISO 14791:2012 risk benefit ratio needs to be incorporated into procedures
Slide 16
Clinical Evaluation (MDR Annex XIV)• Procedures to accommodate new requirements• CER needs to take the entire life cycle of device into consideration• PMCF process including plan and report• Clinical study requirements are much more strict – studies must be performed in line with
legal requirements
Slide 17
Traceability & Registration• UDI is mandatory under MDR / IVDR
• EUDAMED registration is mandatory under MDR / IVDR
Slide 18
Liability Insurance• Mandatory for manufacturers• Agreements with Authorized Representatives need
to include their liability for defective products
Slide 19
Authorized Representatives• Shall ensure AR’s have…
- necessary documentation permanently available- 1 responsible person for regulatory requirements
Slide 20
“Shall” appears….1,697 times in the MDR1,517 times in the IVDR
Compared to….1033 times Subchapter H Medical Devices(including UDI 830 – 27 & PMS 809 – 44)
Slide 22
The Manufacturer Shall…• Establish, document and implement a quality management system, as
described in Article 10(9)[10(8)], and maintain its effectiveness throughout the life cycle of the devices concerned
• Ensure the application of the quality management system as specified in Section 2, and shall be subject to audit as laid down in Sections 2.3 and 2.4 and to surveillance as specified in Section 3
Quality Management System – Annex IX, Chapter 1
Slide 23
The Manufacturer Shall…• Submit “an application for assessment of its quality system with a notified
body” (does not apply to standard Class I devices)
• The application shall include documentation of:- Manufacturer’s QMS - Procedures to ensure QMS will remain adequate and effective- Manufacturer’s post-market surveillance system*- Clinical evaluation plan*- Documented description of the current procedures that meet the obligations
of both the QMS and MDR / IVDR regulations
*Including descriptions of procedures that will keep these up to dateQuality Management System – Annex IX, Chapter 1
Slide 24
Quality Management System Implementation :• Shall ensure compliance with this Regulation• Shall be documented in a systematic and orderly manner in the form of a
quality manual and written policies and procedures• Should include these elements:
a) quality objectivesb) organization of the businessc) procedures and techniques for monitoring, verifying, validating
and controlling the design of the devicesd) verification and quality assurance techniques at the
manufacturing stagee) appropriate tests and trials
Quality Management System – Annex IX, Chapter 1
Slide 25
Audits by Notified Bodies
• Audits will be used by NBs to determine if QMS meets the requirements…- NB will assess conformity with harmonized standard
or CS related a QMS- Conducted on premises of manufacturer, suppliers,
subcontractors
Quality Management System – Annex IX, Chapter 1
Slide 26
Planned Changes to QMS• Manufacturers must inform NB if there are substantial planned changes to
QMS, or device-range covered…- NB will assess changes to determine conformity
Quality Management System – Annex IX, Chapter 1
Slide 27
Surveillance Applicable to…• Class IIa, IIb, III devices• Must provide access to documentation• NB will periodically (at least once every 12 months)
conduct audits and assessments
Quality Management System – Annex IX, Chapter 1
Slide 28
Quality Management requirements also included in:MDR / IVDRAnnex IX – Conformity Assessment Based on a Quality Management System and on Assessment of Technical Documentation
Chapter I - Quality Management SystemMDRAnnex XI – Conformity Assessment Based on Product Conformity Verification
Part A. 6. - Quality Management System
IVDRAnnex XI – Conformity Assessment Based on Production Quality Assurance
Part 3. - Quality Management System
Slide 30
QMS Procedures and Economic Operators*
*Quality Management Systems requirements of the MDR and IVDR, Eamonn Hoxey & Michael Murphy, ABHI Regulatory Conference, 5-October-2017
Manufacturer (Article 10)
Authorized Rep (Article 11&12)
Importer (Article 13)
Distributor(Article 14)
Assembler (Article 22)
Eudamed Registration
Technical Documentation
Handling, storage, and distribution
Nonconformities
Field safety correction action
UDI/Labeling
Complaints
Post-Market Surveillance (PSUR, SSCP)
Persons responsible for regulatory compliance
Design and development, manufacture or assembly
Slide 31
Quality Management System (Annex IX)Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
ISO 13485:2016 Certificate Optional; Must have a Quality System in place that meets requirements of MDR / IVDR based on device risk (classification)
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 32
Declaration of Conformity (Article 56 [Article 17])Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
Notified Body not required. Manufacturer self-declares conformity with MDR including QMS
Notified Body required to assess conformity with MDR *Microbiology & Sterilization Procedures
Notified Body not required. Manufacturer self-declares conformity with IVDR including QMS (other than devices for Performance Study)
Notified Body required to assess conformity with IVDR
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 33
Quality System Audits (Annex IX, Clause 2.3)Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
N/A
Audits performed by Notified Body *Surveillance audits
N/A
Audits performed by Notified Body
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 34
Clinical Evidence (Article 61 [Article 56])
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Class I Class Im*, Ir*, Is*, IIa, IIb, III, Implantables
Class A Class B, C, D
Clinical Evaluation Report Process and Procedures – Class I, IIa
Clinical Evaluation Consultation Procedure (Class III Implants), Clinical Investigational Studies and Report Process and Procedures – Class IIb, III
Performance Evaluation Report • Update throughout life of
device
Performance Evaluation Report • Update at least
annually
Slide 35
Post-Market Surveillance (Article 86 [Article 78])Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
SOP’s and Infrastructure Procedures • PMS Trend Report • Periodic Safety Update
Report (PSUR) – “when necessary” – need to tell when will be done
SOP’s and Infrastructure Procedures • PMS Trend Report • Periodic Safety Update
Report (PSUR) – Class Ir, Is, Im, IIa, IIb, III (Class Ir, Is, Im – update as necessary) (Class IIa – as necessary; at least every 2 years) (Class IIb – Annual) (Class II Implant, Class III – Annually submits via EUDAMED to NB)
• Summary of Safety & Clinical Performance (SSCP) – Class III, Implantables
SOP’s and Infrastructure Procedures • Post-market Surveillance
Report (PSUR) – (Class A, B - update when necessary)
• Make available to NB and CA when requested
• Post-market Performance Follow-up (PMPF)
SOP’s and Infrastructure Procedures • Periodic Safety Update
Reports (PSUR) – (Class C, D – at least annually) (Class D - Annually submits via EUDAMED to NB) (Class C – make available to NB and CA when requested)
• Post-market Performance Follow-up (PMPF)
Slide 36
Registration (Article 29/30/31 [Article 26/27/28])Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
Procedures for registering devices, economic operators and manufacturers
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 37
Unique Device Identification (Article 27 [Art8cle 24])Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
Procedures for managing UDI process – registration, assigning Basic UDI-DI, assigning Device Identifiers, collecting and submitting device data to EUDAMED, change control process for managing device data changes/updating EUDAMED
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 38
Implant Card (Article 18)Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
N/A SOP(s) to manage process for all Implantables N/A N/A
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 39
Translation of labeling content (Annex I)Class I Class Im*, Ir*, Is*, IIa, IIb,
III, Implantables Class A Class B, C, D
Procedures for complying with requirement to ensure device is accompanied by the information set out in Section 23 of Annex I in an official Union language(s) determined by the Member State in which the device is made available to the user or patient.
Procedures for complying with requirement to ensure device is accompanied by the information set out in Section 20 of Annex I in an official Union language(s) determined by the Member State in which the device is made available to the user or patient.
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 40
Technical Documentation (Annex I & II) Procedures for creating and maintaining Technical Files, including documentation for these Safety and Performance Requirements (SPR Number):
Class I Class Im*, Ir*, Is*, IIa, IIb, III, Implantables
Class A Class B, C, D
• Risk Analysis - Comparison to EN ISO 14791:2012 (2, 3, 4, 5, 8)
• Substances that are carcinogenic, mutagenic toxic to reproduction, or endocrine disrupting (10.4)
• Nanomaterials (10.6) • Infection and microbial contamination (11) • Substances that are absorbed and locally dispersed (12.2) • Tissues, cells, or derivatives of human origin (13.1) • Using non-viable biological substances (13.3)
• Risk Analysis - Comparison to EN ISO 14791:2012 (2, 3, 4, 5, 8)
• Performance characteristics shall be maintained during the lifetime of the device as indicated by the manufacturer (9.2)
• Metrological traceability of values assigned to calibrators and/or control materials (9.3)
• Substances that are carcinogenic, mutagenic toxic to reproduction, or endocrine disrupting (10.3)
*Im = Class I measurable; Ir = Class I reusable instruments; Is = Class I sterile
Slide 41
Technical Documentation (Annex I & II) (con’t)
Class I Class Im*, Ir*, Is*, IIa, IIb, III, Implantables
Class A Class B, C, D
• Adjustment, calibration and maintenance: safety and effectiveness (14.4)
• Interoperability and compatibility reliable and safe (14.5) • Safe deposal after use (14.7) • Information security (17.2) • Specific features of mobile platforms (17.3) • Protection against unauthorized access (17.4) • Errors likely to be made when refitting (20.5) • Devices intended for use by lay persons (22) • New requirements for labels and instructions for use (23)
• Infection and microbial contamination (11) • Tissues, cells, or derivatives of human origin (12) • Safe deposal after use (13.6) • Information security (16.2) • Specific features of mobile platforms (16.3) • Protection against unauthorized access (16.4) • Errors likely to be made when refitting (18.7) • Devices intended for self-testing or near-patient testing
(19) • New requirements for labels and instructions for use (20)
*Im = Class I measurable; Ir = Class I reusable; Is = Class I sterile
Slide 42
General obligations of manufacturers (Article 10)
Manufacturers shall ensure that procedures:• are in place to keep series production in conformity with the requirements of this
Regulation• changes in device design or characteristics and changes in the harmonized
standards or CS by reference … shall be adequately taken into account in a timely manner
• Manufacturers of devices, other than investigational devices [other than devices for performance study], shall establish, document, implement, maintain, keep up to date and continually improve a quality management system that shall ensure compliance with this Regulation in the most effective manner and in a manner that is proportionate to the risk class and the type of device. Paragraph 9[8]
Slide 43
General obligations of manufacturers (Article 10)
The quality management system shall:• cover all parts and elements of a manufacturer's organization dealing with the quality
of processes, procedures and devices. • govern the structure, responsibilities, procedures, processes and
management resources required to implement the principles and actions necessary to achieve compliance with the provisions of this Regulation. (Article 10, Paragraph 9[8])
Slide 44
QMS Procedures and Economic Operators*
*Quality Management Systems requirements of the MDR and IVDR, Eamonn Hoxey & Michael Murphy, ABHI Regulatory Conference, 5-October-2017
Manufacturer (Article 10)
Authorized Rep (Article 11&12)
Importer (Article 13)
Distributor(Article 14)
Assembler (Article 22)
Eudamed Registration
Technical Documentation
Handling, storage, and distribution
Nonconformities
Field safety correction action
UDI/Labeling
Complaints
Post-Market Surveillance (PSUR, SSCP)
Persons responsible for regulatory compliance
Design and development, manufacture or assembly
Slide 45
General obligations of Manufacturers (Article 10)
Recommended Procedures and ProcessesMDR /IVDR General Obligations Comparison to FDA
QSR Regulation (§ 820) Comparison to FDA
IVD Regulation (§ 809) Conform with Common Specifications, as required (Article 9) N/A N/A Procedures to monitor for publications of and/or changes in Common Specifications, Implementing Acts and Delegated Acts (Article 1, Annex XVI)
N/A N/A
Procedures to monitor for or identify Member States where reprocessing is permitted, if applicable (Article 2)
N/A N/A
Device are designed and manufactured per MDR requirements. N/A N/A Manufacturer’s shall draw up and keep up-to-date technical documentation (non-custom-made devices) (Article 83)
N/A N/A
Slide 46
General obligations of Manufacturers (Article 10)
Recommended Procedures and ProcessesMDR /IVDR General Obligations Comparison to FDA
QSR Regulation (§ 820) Comparison to FDA
IVD Regulation (§ 809) Manufacturers of custom devices shall draw up and keep up-to-date documentation available for competent authorities (Annex XIII)
N/A N/A
Processes to manage agreements between manufacturers to allow one to use the others clinical evaluation when devices are “equivalent.” (Article 61)
N/A N/A
Person responsible for regulatory compliance (Article 15) § 820.25 § 820.25 Strategy for regulatory compliance (Article 10. Clause 9(a)) § 820.5 § 820.5 Identification of applicable general safety and performance requirements (Article 10. Clause 9(b))
§ 820.30 § 820.30
Responsibility of management (Article 10. Clause 9(e)) § 820.20 § 820.20
Slide 47
General obligations of Manufacturers (Article 10)
Recommended Procedures and ProcessesMDR /IVDR General Obligations Comparison to FDA
QSR Regulation (§ 820) Comparison to FDA
IVD Regulation (§ 809) Resource Management, including selection and control of suppliers and sub-contractors (Article 10. Clause 9(d))
§ 820.50 § 820.50
Risk Analysis and management (Article 10. Clause 9(e)) Guidance Guidance Product realization, including planning, design, development, production and service provision (Article 10. Clause 9(g))
§ 820.30, 820.70, 820.200
§ 820.30, 820.70, 820.200
Verification of UDI assignments (Article 10. Clause 9(h)) § 830 N/A Handling communications with competent authorities, notified bodies, other economic operators, customers and/or other stakeholders (Article 10. Clause 9(j))
Various Various
Processes for reporting serious incidents, field safety corrective actions (Article 10. Clause 9(k))
§ 803 § 803
Slide 48
General obligations of Manufacturers (Article 10)
Recommended Procedures and ProcessesMDR /IVDR General Obligations Comparison to FDA
QSR Regulation (§ 820) Comparison to FDA
IVD Regulation (§ 809) Management of corrective and preventive actions (Article 10. Clause 9(l))
§ 820.100 § 820.100
Process for monitoring and measurement of output, data analysis and product improvement (Article 10. Clause 9(m))
§ 820.30 § 820.30
Label requirements (Article 10. Clause 11) § 801 § 809.10 / § 809.11 Vigilance – Recall and reporting of incidents and field safety corrective actions requirements (Article 10. Clause 12)
§ 806 § 806
Record retention (Article 10. Clause 8) § 820.180 § 820.180 Procedure for communication with Commission/Member States to obtain Single Registration Number (Article 31)
§ 807 § 807
Procedures on requirements for Distributors (Article 14) and Importers (Articles 31 & 13)
N/A N/A
Slide 49
The future is fast approaching…
What you need to do…starting now…• Review Manufacturer requirements and make gap
assessment against your existing QMS • Amend and implement QMS• Apply amended QMS to products
Turning back time is not an option…